Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.
Minenkova O, Santapaola D, Milazzo FM, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Gritti G, Borleri G, Rambaldi A, Dental C, Viollet C, Pagano B, Salvini L, Marra E, Luberto L, Rossi A, Riccio A, Merlo Pich E, Santoro MG, De Santis R. Minenkova O, et al. Among authors: chiapparino c. Mol Ther. 2022 May 4;30(5):1979-1993. doi: 10.1016/j.ymthe.2022.02.013. Epub 2022 Feb 12. Mol Ther. 2022. PMID: 35167974 Free PMC article.
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.
Milazzo FM, Chaves-Sanjuan A, Minenkova O, Santapaola D, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Merlo Pich E, Albertoni C, Marra E, Luberto L, Viollet C, Spagnoli LG, Riccio A, Rossi A, Santoro MG, Ballabio F, Paissoni C, Camilloni C, Bolognesi M, De Santis R. Milazzo FM, et al. Among authors: chiapparino c. Mol Ther. 2023 Feb 1;31(2):362-373. doi: 10.1016/j.ymthe.2022.09.010. Epub 2022 Sep 15. Mol Ther. 2023. PMID: 36114671 Free PMC article.
Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.
De Santis R, Rosi A, Anastasi AM, Chiapparino C, Albertoni C, Leoni B, Pelliccia A, Santapaola D, Carollo V, Marra E, Aurisicchio L, Arseni B, Pacello ML, Palmieri G, Battella S, Petronzelli F, Milazzo FM. De Santis R, et al. Among authors: chiapparino c. Oncotarget. 2014 Oct 15;5(19):9239-55. doi: 10.18632/oncotarget.2409. Oncotarget. 2014. PMID: 25238453 Free PMC article.
Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization.
Inforzato A, Rivieccio V, Morreale AP, Bastone A, Salustri A, Scarchilli L, Verdoliva A, Vincenti S, Gallo G, Chiapparino C, Pacello L, Nucera E, Serlupi-Crescenzi O, Day AJ, Bottazzi B, Mantovani A, De Santis R, Salvatori G. Inforzato A, et al. Among authors: chiapparino c. J Biol Chem. 2008 Apr 11;283(15):10147-61. doi: 10.1074/jbc.M708535200. Epub 2008 Jan 25. J Biol Chem. 2008. PMID: 18223257 Free article.
AvidinOX™ for tissue targeted delivery of biotinylated cells.
Nucera E, Nicoletti C, Chiapparino C, Pacello ML, D'Alessio V, Musarò A, De Santis R. Nucera E, et al. Among authors: chiapparino c. Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):239-46. doi: 10.1177/039463201202500126. Int J Immunopathol Pharmacol. 2012. PMID: 22507336 Free article.
22 results